Arvinas (ARVN) Cash & Equivalents (2017 - 2026)

Arvinas (ARVN) recorded quarterly Cash & Equivalents of $87.3 million in Q1 2026, down 38.91% quarter-over-quarter from $142.9 million in Q4 2025, and up 7.78% on a YoY basis from $81.0 million in Q1 2025.

Arvinas (ARVN) Cash & Equivalents (2017 - 2026) Analysis & Trends

Arvinas' Cash & Equivalents history runs 10 years deep, the most recent figure standing at $87.3 million for Q1 2026.

  • In Q1 2026, Cash & Equivalents rose 7.78% year-over-year to $87.3 million; the TTM figure through Mar 2026 stood at $87.3 million (up 7.78% YoY), while the FY2025 annual figure was $142.9 million, up 42.19% from the prior year.
  • Cash & Equivalents was $87.3 million for Q1 2026 at Arvinas, down from $142.9 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $311.7 million in Q4 2023 to a low of $62.3 million in Q1 2022.
  • Historically, Cash & Equivalents has averaged $116.0 million across 5 years, with a median of $100.5 million in 2024.
  • The sharpest annual moves came in 2022 and 2023: Cash & Equivalents tumbled 82.0% in 2022, then soared 283.39% in 2023.
  • A 5-year view of Cash & Equivalents shows it stood at $81.3 million in 2022, then jumped by 283.39% to $311.7 million in 2023, then tumbled by 67.76% to $100.5 million in 2024, then soared by 42.19% to $142.9 million in 2025, then slumped by 38.91% to $87.3 million in 2026.
  • The last three Cash & Equivalents figures came in at $87.3 million (Q1 2026), $142.9 million (Q4 2025), and $101.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 32.30 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 1.91 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 286.70 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 18.44 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 2.77 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 7.15 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 5.49 Bn
9 Abivax 91.96 Bn 91.96 Bn - 558.94 Mn
10 Arvinas 492.16 Mn -122.74 Mn - 87.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 87.30 Mn
Dec 31, 2025 142.90 Mn
Sep 30, 2025 101.50 Mn
Jun 30, 2025 114.90 Mn
Mar 31, 2025 81.00 Mn
Dec 31, 2024 100.50 Mn
Sep 30, 2024 85.20 Mn
Jun 30, 2024 154.80 Mn
Mar 31, 2024 88.00 Mn
Dec 31, 2023 311.70 Mn
Sep 30, 2023 113.70 Mn
Jun 30, 2023 90.60 Mn
Mar 31, 2023 130.20 Mn
Dec 31, 2022 81.30 Mn
Sep 30, 2022 132.60 Mn
Jun 30, 2022 93.20 Mn
Mar 31, 2022 62.30 Mn
Dec 31, 2021 108.30 Mn
Sep 30, 2021 255.66 Mn
Jun 30, 2021 48.73 Mn